Regeneron Pharmaceuticals, Inc.
Sector: Manufacturing
Industry: Pharmaceutical Products
563.16
13.88
(2.53%)
Volume:
827,805
52 week range:
525.99 - 1,209.65
Market Cap:
61.567B
Company Description:
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema. Dupixent injection is used to treat atopic dermatitis and asthma in adults and pediatrics. Kevzara solution for treating rheumatoid arthritis in adults.